Casanova, M. Isabel
Park, Sangwan
Mayes, Melaney A.
Roszak, Karolina
Ferneding, Michelle
Echeverria, Nayeli
Bowman, Morgan A. W.
Michalak, Sarah R.
Ardon, Monica
Wong, Sydni
Le, Sophie M.
Daley, Nicole
Leonard, Brian C.
Good, Kathryn L.
Li, Jennifer Y.
Thomasy, Sara M.
Funding for this research was provided by:
National Institutes of Health (K08EY028199, R01EY016134)
American Kennel Club Canine Health Foundation (02696)
Center for Companion Animal Health, University of California, Davis
Article History
Received: 20 October 2023
Accepted: 1 March 2024
First Online: 14 March 2024
Competing interests
: Netarsudil (Rhopressa®) and its vehicle were donated by Aerie Pharmaceuticals. However, Aerie Pharmaceuticals had no input in the study design, analysis or interpretation of the data presented in the manuscript.